These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29987391)

  • 1. Safety Assessment of Formulation Vehicles Following Intravitreal Administration in Rabbits.
    Aguirre SA; Gukasyan HJ; Younis HS; Huang W
    Pharm Res; 2018 Jul; 35(9):173. PubMed ID: 29987391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the ocular safety of inactive excipients following sub-tenon injection in rabbits.
    Younis HS; Shawer M; Palacio K; Gukasyan HJ; Stevens GJ; Evering W
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):206-16. PubMed ID: 18345993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of the ocular safety of excipient maleic acid following intravitreal injection in rabbits.
    Aguirre SA; Collette W; Gukasyan HJ; Huang W
    Toxicol Pathol; 2012 Jul; 40(5):797-806. PubMed ID: 22552388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability Assessment of Formulation pH in New Zealand White Rabbits Following Intravitreal Administration.
    Tassew NG; Laing ST; Aaronson J; de Jong I; Schuetz C; Lorget F
    Toxicol Pathol; 2021 Apr; 49(3):605-609. PubMed ID: 33252028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection.
    Chiang B; Venugopal N; Edelhauser HF; Prausnitz MR
    Exp Eye Res; 2016 Dec; 153():101-109. PubMed ID: 27742547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and pharmacokinetics of intravitreal sirolimus.
    Mudumba S; Bezwada P; Takanaga H; Hosoi K; Tsuboi T; Ueda K; Kawazu K; Ali Y; Naor J
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):507-14. PubMed ID: 22662868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of a No-Observable Effect Level for Endotoxin Following a Single Intravitreal Administration to Dutch Belted Rabbits.
    Bantseev V; Miller PE; Bentley E; Schuetz C; Streit TM; Christian BJ; Farman C; Booler H; Thackaberry EA
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1545-1552. PubMed ID: 28282486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural surfactant-based topical vehicles for two model drugs: Influence of different lipophilic excipients on in vitro/in vivo skin performance.
    Savić S; Weber C; Savić MM; Müller-Goymann C
    Int J Pharm; 2009 Nov; 381(2):220-30. PubMed ID: 19616085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical application of povidone-iodine/dimethylsulfoxide ophthalmic gel preparation in Dutch-Belted rabbits.
    Pelletier JS; Devine J; Capriotti K; Barone SB; Capriotti JA
    Cutan Ocul Toxicol; 2019 Sep; 38(3):221-226. PubMed ID: 30741035
    [No Abstract]   [Full Text] [Related]  

  • 11. Solution formulation development of a VEGF inhibitor for intravitreal injection.
    Marra MT; Khamphavong P; Wisniecki P; Gukasyan HJ; Sueda K
    AAPS PharmSciTech; 2011 Mar; 12(1):362-71. PubMed ID: 21312012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Acute Ocular Safety Study of Combined Intravitreal Carboplatin and Etoposide Phosphate for Retinoblastoma.
    Mohney BG; Elner VM; Smith AB; Harbour JW; Smith BD; Musch DC; Smith SJ
    Ophthalmic Surg Lasers Imaging Retina; 2017 Feb; 48(2):151-159. PubMed ID: 28195618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Carnosine: multifunctional dipeptide buffer for sustained-duration topical ophthalmic formulations.
    Singh SR; Carreiro ST; Chu J; Prasanna G; Niesman MR; Collette Iii WW; Younis HS; Sartnurak S; Gukasyan HJ
    J Pharm Pharmacol; 2009 Jun; 61(6):733-42. PubMed ID: 19505363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subchronic (26- and 52-week) toxicity and irritation studies of a novel microbicidal gel formulation containing sodium lauryl sulfate in animal models.
    Piret J; Laforest G; Bussières M; Bergeron MG
    J Appl Toxicol; 2008 Mar; 28(2):164-74. PubMed ID: 17549701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term tolerance of preservative-free eye drops containing macrogol hydroxystearate as an excipient.
    Viaud-Quentric K; Lefranc-Jullien S; Feraille L; Elena PP
    J Fr Ophtalmol; 2016 Feb; 39(2):156-63. PubMed ID: 26832317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.
    Oliveira RC; Messias A; Siqueira RC; Bonini-Filho MA; Haddad A; Damico FM; Maia-Filho A; Crispim PT; Saliba JB; Ribeiro JA; Scott IU; Cunha AS; Jorge R
    Curr Eye Res; 2012 Jan; 37(1):55-61. PubMed ID: 22029458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of intravitreal clindamycin in albino rabbit eyes.
    Habot-Wilner Z; Mazza O; Shahar J; Massarweh A; Mann I; Loewenstein A; Perlman I
    Doc Ophthalmol; 2017 Oct; 135(2):133-146. PubMed ID: 28744691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal injection of polysorbate 80: a functional and morphological study.
    Damico FM; Gasparin F; Ioshimoto GL; Igami TZ; Cunha ADS; Fialho SL; Liber AM; Young LH; Ventura DF
    Rev Col Bras Cir; 2017; 44(6):603-611. PubMed ID: 29267557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicological and pharmacokinetic properties of QPI-1007, a chemically modified synthetic siRNA targeting caspase 2 mRNA, following intravitreal injection.
    Solano EC; Kornbrust DJ; Beaudry A; Foy JW; Schneider DJ; Thompson JD
    Nucleic Acid Ther; 2014 Aug; 24(4):258-66. PubMed ID: 25054518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.